Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects

Emanuele Cozzani, Giulia Gasparini, Martina Burlando, Francesco Drago, Aurora Parodi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Bullous pemphigoid may occur in extremely variegated manners, misleading even experienced dermatologists. Indeed the type and/or distribution of lesions may be unusual. Furthermore, there may be an atypical demographic profile of patients, a different clinical course and a different responsiveness to therapy. Up to 20% of the cases the onset is characterized by a non-bullous phase, lasting weeks, months or in particular cases remaining the only manifestation of the disease. During this early phase lesions are generally pruritic erythematous, eczematous or urticarial; however, lesions may also resemble polycyclic, targetoid, nodular or lichenoid lesions. These atypical lesions may also coexist with typical bullae. Other atypical presentations include a vesicular eruption and an erythroderma. Manifestations in children differ from adult forms, presenting an exclusive genital involvement in 50% of cases or a preponderant involvement of the face, the palms and the soles. Rarely bullous pemphigoid is confined to certain body areas, due to particular triggering factors or to a lower disease activity. Therefore, the need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid. Direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful.

Original languageEnglish
Pages (from-to)438-445
Number of pages8
JournalAutoimmunity Reviews
Volume14
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Bullous Pemphigoid
Exfoliative Dermatitis
Direct Fluorescent Antibody Technique
Blister
Autoantibodies
Demography
Skin
Therapeutics

Keywords

  • Atypical presentation
  • Autoimmune blistering diseases
  • Bullous pemphigoid
  • Clinical variants
  • Diagnosis
  • Diagnostic criteria

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Atypical presentations of bullous pemphigoid : Clinical and immunopathological aspects. / Cozzani, Emanuele; Gasparini, Giulia; Burlando, Martina; Drago, Francesco; Parodi, Aurora.

In: Autoimmunity Reviews, Vol. 14, No. 5, 01.05.2015, p. 438-445.

Research output: Contribution to journalArticle

Cozzani, Emanuele ; Gasparini, Giulia ; Burlando, Martina ; Drago, Francesco ; Parodi, Aurora. / Atypical presentations of bullous pemphigoid : Clinical and immunopathological aspects. In: Autoimmunity Reviews. 2015 ; Vol. 14, No. 5. pp. 438-445.
@article{905d394e21854782a27e62307a543ca6,
title = "Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects",
abstract = "Bullous pemphigoid may occur in extremely variegated manners, misleading even experienced dermatologists. Indeed the type and/or distribution of lesions may be unusual. Furthermore, there may be an atypical demographic profile of patients, a different clinical course and a different responsiveness to therapy. Up to 20{\%} of the cases the onset is characterized by a non-bullous phase, lasting weeks, months or in particular cases remaining the only manifestation of the disease. During this early phase lesions are generally pruritic erythematous, eczematous or urticarial; however, lesions may also resemble polycyclic, targetoid, nodular or lichenoid lesions. These atypical lesions may also coexist with typical bullae. Other atypical presentations include a vesicular eruption and an erythroderma. Manifestations in children differ from adult forms, presenting an exclusive genital involvement in 50{\%} of cases or a preponderant involvement of the face, the palms and the soles. Rarely bullous pemphigoid is confined to certain body areas, due to particular triggering factors or to a lower disease activity. Therefore, the need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid. Direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful.",
keywords = "Atypical presentation, Autoimmune blistering diseases, Bullous pemphigoid, Clinical variants, Diagnosis, Diagnostic criteria",
author = "Emanuele Cozzani and Giulia Gasparini and Martina Burlando and Francesco Drago and Aurora Parodi",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.autrev.2015.01.006",
language = "English",
volume = "14",
pages = "438--445",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Atypical presentations of bullous pemphigoid

T2 - Clinical and immunopathological aspects

AU - Cozzani, Emanuele

AU - Gasparini, Giulia

AU - Burlando, Martina

AU - Drago, Francesco

AU - Parodi, Aurora

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Bullous pemphigoid may occur in extremely variegated manners, misleading even experienced dermatologists. Indeed the type and/or distribution of lesions may be unusual. Furthermore, there may be an atypical demographic profile of patients, a different clinical course and a different responsiveness to therapy. Up to 20% of the cases the onset is characterized by a non-bullous phase, lasting weeks, months or in particular cases remaining the only manifestation of the disease. During this early phase lesions are generally pruritic erythematous, eczematous or urticarial; however, lesions may also resemble polycyclic, targetoid, nodular or lichenoid lesions. These atypical lesions may also coexist with typical bullae. Other atypical presentations include a vesicular eruption and an erythroderma. Manifestations in children differ from adult forms, presenting an exclusive genital involvement in 50% of cases or a preponderant involvement of the face, the palms and the soles. Rarely bullous pemphigoid is confined to certain body areas, due to particular triggering factors or to a lower disease activity. Therefore, the need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid. Direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful.

AB - Bullous pemphigoid may occur in extremely variegated manners, misleading even experienced dermatologists. Indeed the type and/or distribution of lesions may be unusual. Furthermore, there may be an atypical demographic profile of patients, a different clinical course and a different responsiveness to therapy. Up to 20% of the cases the onset is characterized by a non-bullous phase, lasting weeks, months or in particular cases remaining the only manifestation of the disease. During this early phase lesions are generally pruritic erythematous, eczematous or urticarial; however, lesions may also resemble polycyclic, targetoid, nodular or lichenoid lesions. These atypical lesions may also coexist with typical bullae. Other atypical presentations include a vesicular eruption and an erythroderma. Manifestations in children differ from adult forms, presenting an exclusive genital involvement in 50% of cases or a preponderant involvement of the face, the palms and the soles. Rarely bullous pemphigoid is confined to certain body areas, due to particular triggering factors or to a lower disease activity. Therefore, the need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid. Direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful.

KW - Atypical presentation

KW - Autoimmune blistering diseases

KW - Bullous pemphigoid

KW - Clinical variants

KW - Diagnosis

KW - Diagnostic criteria

UR - http://www.scopus.com/inward/record.url?scp=84925164455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925164455&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2015.01.006

DO - 10.1016/j.autrev.2015.01.006

M3 - Article

C2 - 25617817

AN - SCOPUS:84925164455

VL - 14

SP - 438

EP - 445

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 5

ER -